Obesity and addiction: Neurobiological overlaps

Obesity Reviews

Volumn 14, Issue 1, 2013, Pages 2-18

  Volkow, N D ^a   Wang, G J ^b   Tomasi, D ^b   Baler, R D ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b BROOKHAVEN NATIONAL LABORATORY   (United States)

Author keywords

Addiction; Dopamine; Obesity; Prefrontal cortex

Indexed keywords

AMPHETAMINE; CANNABINOID; CHOLECYSTOKININ; CHOLECYSTOKININ RECEPTOR; COCAINE; COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT PEPTIDE; CORTICOTROPIN RELEASING FACTOR; DIAMORPHINE; DOPAMINE; DOPAMINE RECEPTOR; EXENDIN 4; GALANIN; GHRELIN; GLUCAGON LIKE PEPTIDE 1; INSULIN; LEPTIN; MELANOCORTIN; MELANOCORTIN 2 RECEPTOR; MELANOCORTIN 4 RECEPTOR; METHAMPHETAMINE; NARCOTIC ANALGESIC AGENT; NEUROPEPTIDE Y; NEUROTRANSMITTER; OPIATE; OREXIN; OXYTOCIN; PEPTIDE YY; PSYCHOSTIMULANT AGENT; RECOMBINANT LEPTIN; UNINDEXED DRUG;

AMYGDALOID NUCLEUS; BRAIN FUNCTION; CENTRAL NERVOUS SYSTEM; DRUG DEPENDENCE; ENERGY BALANCE; ENVIRONMENTAL FACTOR; FEEDING BEHAVIOR; FOOD INTAKE; HOMEOSTASIS; HUMAN; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HYPOTHALAMUS; INSULIN BLOOD LEVEL; LEARNING; MEDIATOR; MEMORY; MOTIVATION; NERVE CELL NETWORK; NEUROBIOLOGY; NEUROMODULATION; NEUROPATHOLOGY; NONHUMAN; OBESITY; PANCREAS; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REINFORCEMENT; REVIEW; REWARD; SATIETY; SIGNAL TRANSDUCTION; SMALL INTESTINE; STOMACH;

BEHAVIOR, ADDICTIVE; BRAIN; COMORBIDITY; DOPAMINE; EATING; HUMANS; MODELS, BIOLOGICAL; NEURAL PATHWAYS; OBESITY; REWARD; SUBSTANCE-RELATED DISORDERS;

EID: 84871241900     PISSN: 14677881     EISSN: 1467789X     Source Type: Journal    
DOI: 10.1111/j.1467-789X.2012.01031.x     Document Type: Review

References (226)

1. Volkow ND, O'Brien CP. Issues for DSM-V: should obesity be included as a brain disorder? Am J Psychiatry 2007; 164: 708-710.
2. Volkow ND, Wang GJ, Fowler JS, Tomasi D, Baler R. Food and drug reward: overlapping circuits in human obesity and addiction. Curr Top Behav Neurosci 2011; 11: 1-24.
3. Ziauddeen H, Fletcher P. Is food addiction a valid and useful concept? Obes Rev 2012; in press.
4. Spear HB. The growth of heroin addiction in the United Kingdom. Br J Addict Alcohol Other Drugs 1969; 64: 245-255.
5. Goldstein A. Addiction: From Biology to Drug Policy, 2nd edn. Oxford University Press: New York, 2001.
6. Alamar B, Glantz SA. Modeling addictive consumption as an infectious disease. Contrib Econ Analysis Policy 2006; 5: 1-22.
7. Koob GF, Le Moal M. Drug abuse: hedonic homeostatic dysregulation. Science 1997; 278: 52-58.
8. Volkow ND, Wang GJ, Fowler JS, Tomasi D, Telang F, Baler R. Addiction: decreased reward sensitivity and increased expectation sensitivity conspire to overwhelm the brain's control circuit. BioEssay 2010; 32: 748-755.
9. Umberg EN, Shader RI, Hsu LK, Greenblatt DJ. From disordered eating to addiction: the 'food drug' in bulimia nervosa. J Clin Psychopharmacol 2012; 32: 376-389.
10. Speranza M, Revah-Levy A, Giquel L etal. An investigation of Goodman's addictive disorder criteria in eating disorders. Eur Eat Disord Rev 2011; 20: 182-189.
11. Schloegl H, Percik R, Horstmann A, Villringer A, Stumvoll M. Peptide hormones regulating appetite - focus on neuroimaging studies in humans. Diabetes Metab Res Rev 2011; 27: 104-112.
12. Csete M, Doyle J. Bow ties, metabolism and disease. Trends Biotechnol 2004; 22: 446-450.
13. Lenoir M, Serre F, Cantin L, Ahmed SH. Intense sweetness surpasses cocaine reward. Plos ONE 2007; 2: e698.
14. Avena NM, Rada P, Hoebel BG. Evidence for sugar addiction: behavioral and neurochemical effects of intermittent, excessive sugar intake. Neurosci Biobehav Rev 2008; 32: 20-39.
15. Avena NM, Rada P, Hoebel BG. Sugar and fat bingeing have notable differences in addictive-like behavior. J Nutr 2009; 139: 623-628.
16. Corsica JA, Pelchat ML. Food addiction: true or false? Curr Opin Gastroenterol 2010; 26: 165-169.
17. Garber AK, Lustig RH. Is fast food addictive? Curr Drug Abuse Rev 2011; 4: 146-162.
18. Atkinson TJ. Central and peripheral neuroendocrine peptides and signalling in appetite regulation: considerations for obesity pharmacotherapy. Obes Rev 2008; 9: 108-120.
19. Cota D, Tschop MH, Horvath TL, Levine AS. Cannabinoids, opioids and eating behavior: the molecular face of hedonism? Brain Res Rev 2006; 51: 85-107.
20. Cason AM, Smith RJ, Tahsili-Fahadan P, Moorman DE, Sartor GC, Aston-Jones G. Role of orexin/hypocretin in reward-seeking and addiction: implications for obesity. Physiol Behav 2010; 100: 419-428.
21. Dickson S, Shirazi RH, Hansson C, Bergquist F, Nissbrandt H, Skibicka KP. The glucagon-like peptide 1 (GLP-1) analogue, Exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptors. J Neurosci 2012; 32: 4812-4820.
22. Norgren R, Hajnal A, Mungarndee SS. Gustatory reward and the nucleus accumbens. Physiol Behav 2006; 89: 531-535.
23. Opland DM, Leinninger GM, Myers MG Jr. Modulation of the mesolimbic dopamine system by leptin. Brain Res 2011; 1350: 65-70.
24. Alhadeff AL, Rupprecht LE, Hayes MR. GLP-1 neurons in the nucleus of the solitary tract project directly to the ventral tegmental area and nucleus accumbens to control for food intake. Endocrinology 2012; 153: 647-658.
25. Rinaman L. Ascending projections from the caudal visceral nucleus of the solitary tract to brain regions involved in food intake and energy expenditure. Brain Res 2010; 1350: 18-34.
26. Abizaid A, Liu ZW, Andrews ZB etal. Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite. J Clin Invest 2006; 116: 3229-3239.
27. Jerlhag E, Egecioglu E, Dickson SL, Douhan A, Svensson L, Engel JA. Ghrelin administration into tegmental areas stimulates locomotor activity and increases extracellular concentration of dopamine in the nucleus accumbens. Addict Biol 2007; 12: 6-16.
28. Figlewicz D, Evans SB, Murphy J, Hoen M, Myers M, Baskin DG. Expression of receptors for insulin and leptin in the ventral tegmental area/substantia nigra (VTA/SN) of the rat. Brain Res 2003; 964: 107-115.
29. Leshan R, Opland DM, Louis GW etal. Ventral tegmental area leptin receptor neurons specifically project to and regulate cocaine- and amphetamine-regulated transcript neurons of the extended central amygdala. J Neurosci 2010; 30: 5713-5723.
30. Figlewicz D, Bennett JL, Aliakbari S, Zavosh A, Sipols AJ. Insulin acts at different CNS sites to decrease acute sucrose intake and sucrose self-administration in rats. Am J Physiol Regul Integr Comp Physiol 2008; 295: R388-394.
31. Fadel J, Deutch AY. Anatomical substrates of orexin-dopamine interactions: lateral hypothalamic projections to the ventral tegmental area. Neuroscience 2002; 111: 379-387.
32. Davis JF, Choi DL, Shurdak JD etal. Central melanocortins modulate mesocorticolimbic activity and food seeking behavior in the rat. Physiol Behav 2011; 102: 491-495.
33. Davis JF, Tracy AL, Schurdak JD etal. Exposure to elevated levels of dietary fat attenuates psychostimulant reward and mesolimbic dopamine turnover in the rat. Behav Neurosci 2008; 122: 1257-1263.
34. Wellman PJ, Nation JR, Davis KW. Impairment of acquisition of cocaine self-administration in rats maintained on a high-fat diet. Pharmacol Biochem Behav 2007; 88: 89-93.
35. Bluml V, Kapusta N, Vyssoki B, Kogoj D, Walter H, Lesch OM. Relationship between substance use and body mass index in young males. Am J Addict 2012; 21: 72-77.
36. Simon G, Von Korff M, Saunders K etal. Association between obesity and psychiatric disorders in the US adult population. Arch Gen Psychiatry 2006; 63: 824-830.
37. Blendy JA, Strasser A, Walters CL etal. Reduced nicotine reward in obesity: cross-comparison in human and mouse. Psychopharmacology (Berl) 2005; 180: 306-315.
38. Warren M, Frost-Pineda K, Gold M. Body mass index and marijuana use. J Addict Dis 2005; 24: 95-100.
39. Davis JF, Choi DL, Benoit SC. Insulin, leptin and reward. Trends Endocrinol Metab 2010; 21: 68-74.
40. Thanos PK, Michaelides M, Piyis YK, Wang GJ, Volkow ND. Food restriction markedly increases dopamine D2 receptor (D2R) in a rat model of obesity as assessed with in-vivo muPET imaging ([11C] raclopride) and in-vitro ([3H] spiperone) autoradiography. Synapse 2008; 62: 50-61.
41. Dunn JP, Kessler RM, Feurer ID etal. Relationship of dopamine type 2 receptor binding potential with fasting neuroendocrine hormones and insulin sensitivity in human obesity. Diabetes Care 2012; 35: 1105-1111.
42. Lent MR, Swencionis C. Addictive personality and maladaptive eating behaviors in adults seeking bariatric surgery. Eat Behav 2012; 13: 67-70.
43. King WC, Chen JY, Mitchell JE etal. Prevalence of alcohol use disorders before and after bariatric surgery. JAMA 2012; 307: 2516-2525.
44. Small DM, Jones-Gotman M, Dagher A. Feeding-induced dopamine release in dorsal striatum correlates with meal pleasantness ratings in healthy human volunteers. Neuroimage 2003; 19: 1709-1715.
45. Volkow ND, Wang GJ, Fowler JS, Telang F. Overlapping neuronal circuits in addiction and obesity: evidence of systems pathology. Philos Trans R Soc Lond B Biol Sci 2008; 363: 3191-3200.
46. Burger KS, Stice E. Frequent ice cream consumption is associated with reduced striatal response to receipt of an ice cream-based milkshake. Am J Clin Nutr 2012; 95: 810-817.
47. Volkow ND, Wang GJ, Baler RD. Reward, dopamine and the control of food intake: implications for obesity. Trends Cogn Sci 2011; 15: 37-46.
48. Owesson-White CA, Ariansen J, Stuber GD etal. Neural encoding of cocaine-seeking behavior is coincident with phasic dopamine release in the accumbens core and shell. Eur J Neurosci 2009; 30: 1117-1127.
49. Schultz W. Dopamine signals for reward value and risk: basic and recent data. Behav Brain Funct 2010; 6: 24.
50. Robbins TW, Cador M, Taylor JR, Everitt BJ. Limbic-striatal interactions in reward-related processes. Neurosci Biobehav Rev 1989; 13: 155-162.
51. Geisler S, Wise RA. Functional implications of glutamatergic projections to the ventral tegmental area. Rev Neurosci 2008; 19: 227-244.
52. Liu T, Kong D, Shah BP etal. Fasting activation of AgRP neurons requires NMDA receptors and involves spinogenesis and increased excitatory tone. Neuron 2012; 73: 511-522.
53. Petrovich GD. Forebrain circuits and control of feeding by learned cues. Neurobiol Learn Mem 2010; 95: 152-158.
54. Lasseter HC, Wells AM, Xie X, Fuchs RA. Interaction of the basolateral amygdala and orbitofrontal cortex is critical for drug context-induced reinstatement of cocaine-seeking behavior in rats. Neuropsychopharmacology 2011; 36: 711-720.
55. See RE. Neural substrates of cocaine-cue associations that trigger relapse. Eur J Pharmacol 2005; 526: 140-146.
56. Wang GJ, Volkow ND, Telang F etal. Evidence of gender differences in the ability to inhibit brain activation elicited by food stimulation. Proc Natl Acad Sci U S A 2009; 106: 1249-1254.
57. Volkow ND, Fowler JS, Wang GJ etal. Cognitive control of drug craving inhibits brain reward regions in cocaine abusers. Neuroimage 2009; 49: 2536-2543.
58. Kearns DN, Gomez-Serrano MA, Tunstall BJ. A review of preclinical research demonstrating that drug and non-drug reinforcers differentially affect behavior. Curr Drug Abuse Rev 2011; 4: 261-269.
59. Rudenga KJ, Sinha R, Small DM. Acute stress potentiates brain response to milkshake as a function of body weight and chronic stress. Int J Obes (Lond) 2012; doi: 10.1038/ijo.2012.39. [Epub ahead of print].
60. Bragulat V, Dzemidzic M, Bruno C etal. Food-related odor probes of brain reward circuits during hunger: a pilot FMRI study. Obesity (Silver Spring) 2012; 18: 1566-1571.
61. Stockburger J, Schmalzle R, Flaisch T, Bublatzky F, Schupp HT. The impact of hunger on food cue processing: an event-related brain potential study. Neuroimage 2009; 47: 1819-1829.
62. Volkow ND, Fowler JS. Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. Cereb Cortex 2000; 10: 318-325.
63. Volkow ND, Wang GJ, Telang F etal. Low dopamine striatal D2 receptors are associated with prefrontal metabolism in obese subjects: possible contributing factors. Neuroimage 2008; 42: 1537-1543.
64. Volkow ND, Fowler JS, Wang GJ, Baler R, Telang F. Imaging dopamine's role in drug abuse and addiction. Neuropharmacology 2009; 56 (Suppl. 1): 3-8.
65. Thanos PK, Michaelides M, Benveniste H, Wang GJ, Volkow ND. Effects of chronic oral methylphenidate on cocaine self-administration and striatal dopamine D2 receptors in rodents. Pharmacol Biochem Behav 2007; 87: 426-433.
66. Nader MA, Morgan D, Gage HD etal. PET imaging of dopamine D2 receptors during chronic cocaine self-administration in monkeys. Nat Neurosci 2006; 9: 1050-1056.
67. Volkow ND, Chang L, Wang GJ etal. Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry 2001; 158: 2015-2021.
68. Ferguson SM, Eskenazi D, Ishikawa M etal. Transient neuronal inhibition reveals opposing roles of indirect and direct pathways in sensitization. Nat Neurosci 2011; 14: 22-24.
69. Thanos PK, Michaelides M, Umegaki H, Volkow ND. D2R DNA transfer into the nucleus accumbens attenuates cocaine self-administration in rats. Synapse 2008; 62: 481-486.
70. Thanos PK, Volkow ND, Freimuth P etal. Overexpression of dopamine D2 receptors reduces alcohol self-administration. J Neurochem 2001; 78: 1094-1103.
71. Ferguson SM, Eskenazi D, Ishikawa M etal. Transient neuronal inhibition reveals opposing roles of indirect and direct pathways in sensitization. Nat Neurosci 2010; 14: 22-24.
72. Hikida T, Kimura K, Wada N, Funabiki K, Nakanishi S. Distinct roles of synaptic transmission in direct and indirect striatal pathways to reward and aversive behavior. Neuron 2010; 66: 896-907.
73. Lobo MK, Covington HE 3rd, Chaudhury D etal. Cell type-specific loss of BDNF signaling mimics optogenetic control of cocaine reward. Science 2010; 330: 385-390.
74. Volkow ND, Fowler JS, Wang GJ etal. Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse 1993; 14: 169-177.
75. Volkow ND, Wang GJ, Telang F etal. Profound decreases in dopamine release in striatum in detoxified alcoholics: possible orbitofrontal involvement. J Neurosci 2007; 27: 12700-12706.
76. Goldstein RZ, Volkow ND. Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry 2002; 159: 1642-1652.
77. Volkow ND, Wang GJ, Begleiter H etal. High levels of dopamine D2 receptors in unaffected members of alcoholic families: possible protective factors. Arch Gen Psychiatry 2006; 63: 999-1008.
78. Ersche KD, Jones PS, Williams GB, Turton AJ, Robbins TW, Bullmore ET. Abnormal brain structure implicated in stimulant drug addiction. Science 2012; 335: 601-604.
79. Parvaz MA, Maloney T, Moeller SJ etal. Sensitivity to monetary reward is most severely compromised in recently abstaining cocaine addicted individuals: a cross-sectional ERP study. Psychiatry Res 2012; 203: 75-82.
80. Geiger BM, Haburcak M, Avena NM, Moyer MC, Hoebel BG, Pothos EN. Deficits of mesolimbic dopamine neurotransmission in rat dietary obesity. Neuroscience 2009; 159: 1193-1199.
81. Wang GJ, Volkow ND, Logan J etal. Brain dopamine and obesity. Lancet 2001; 357: 354-357.
82. de Weijer BA, van de Giessen E, van Amelsvoort TA etal. Lower striatal dopamine D2/3 receptor availability in obese compared with non-obese subjects. EJNMMI Res 2012; 1: 37.
83. Steele KE, Prokopowicz GP, Schweitzer MA etal. Alterations of central dopamine receptors before and after gastric bypass surgery. Obes Surg 2010; 20: 369-374.
84. Johnson PM, Kenny PJ. Dopamine D2 receptors in addiction-like reward dysfunction and compulsive eating in obese rats. Nat Neurosci 2010; 13: 635-641.
85. Fineberg NA, Potenza MN, Chamberlain SR etal. Probing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative review. Neuropsychopharmacology 2009; 35: 591-604.
86. Davis LM, Michaelides M, Cheskin LJ etal. Bromocriptine administration reduces hyperphagia and adiposity and differentially affects dopamine D2 receptor and transporter binding in leptin-receptor-deficient Zucker rats and rats with diet-induced obesity. Neuroendocrinology 2009; 89: 152-162.
87. Holsen LM, Savage CR, Martin LE etal. Importance of reward and prefrontal circuitry in hunger and satiety: Prader-Willi syndrome vs. simple obesity. Int J Obes (Lond) 2012; 36: 638-647.
88. Geiger BM, Behr GG, Frank LE etal. Evidence for defective mesolimbic dopamine exocytosis in obesity-prone rats. FASEB J 2008; 22: 2740-2746.
89. Stoeckel LE, Weller RE, Cook EW 3rd, Twieg DB, Knowlton RC, Cox JE. Widespread reward-system activation in obese women in response to pictures of high-calorie foods. Neuroimage 2008; 41: 636-647.
90. Killgore WD, Yurgelun-Todd DA. Body mass predicts orbitofrontal activity during visual presentations of high-calorie foods. Neuroreport 2005; 16: 859-863.
91. Stice E, Spoor S, Bohon C, Veldhuizen MG, Small DM. Relation of reward from food intake and anticipated food intake to obesity: a functional magnetic resonance imaging study. J Abnorm Psychol 2008; 117: 924-935.
92. Wang GJ, Volkow ND, Felder C etal. Enhanced resting activity of the oral somatosensory cortex in obese subjects. Neuroreport 2002; 13: 1151-1155.
93. Stice E, Spoor S, Bohon C, Small DM. Relation between obesity and blunted striatal response to food is moderated by TaqIA A1 allele. Science 2008; 322: 449-452.
94. Volkow ND, Wang GJ, Fowler JS etal. Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature 1997; 386: 830-833.
95. Wang GJ, Geliebter A, Volkow ND etal. Enhanced striatal dopamine release during food stimulation in binge eating disorder. Obesity 2011; 19: 1601-1608.
96. Haltia LT, Rinne JO, Merisaari H etal. Effects of intravenous glucose on dopaminergic function in the human brain in vivo. Synapse 2007; 61: 748-756.
97. Willeumier KC, Taylor DV, Amen DG. Elevated BMI is associated with decreased blood flow in the prefrontal cortex using SPECT imaging in healthy adults. Obesity (Silver Spring) 2011; 19: 1095-1097.
98. Volkow ND, Wang GJ, Telang F etal. Inverse association between BMI and prefrontal metabolic activity in healthy adults. Obesity 2009; 17: 60-65.
99. Bickel WK, Miller ML, Yi R, Kowal BP, Lindquist DM, Pitcock JA. Behavioral and neuroeconomics of drug addiction: competing neural systems and temporal discounting processes. Drug Alcohol Depend 2007; 90 (Suppl. 1): S85-S91.
100. Brogan A, Hevey D, Pignatti R. Anorexia, bulimia, and obesity: shared decision making deficits on the Iowa Gambling Task (IGT). J Int Neuropsychol Soc 2010; 16: 711-715.
101. Weller RE, Cook EW 3rd, Avsar KB, Cox JE. Obese women show greater delay discounting than healthy-weight women. Appetite 2008; 51: 563-569.
102. Kishinevsky FI, Cox JE, Murdaugh DL, Stoeckel LE, Cook EW 3rd, Weller RE. fMRI reactivity on a delay discounting task predicts weight gain in obese women. Appetite 2012; 58: 582-592.
103. Ikeda S, Kang MI, Ohtake F. Hyperbolic discounting, the sign effect, and the body mass index. J Health Econ 2010; 29: 268-284.
104. Gregorios-Pippas L, Tobler PN, Schultz W. Short-term temporal discounting of reward value in human ventral striatum. J Neurophysiol 2009; 101: 1507-1523.
105. Bjork JM, Momenan R, Hommer DW. Delay discounting correlates with proportional lateral frontal cortex volumes. Biol Psychiatry 2009; 65: 710-713.
106. Bezzina G, Body S, Cheung TH etal. Effect of disconnecting the orbital prefrontal cortex from the nucleus accumbens core on inter-temporal choice behaviour: a quantitative analysis. Behav Brain Res 2008; 191: 272-279.
107. Pine A, Shiner T, Seymour B, Dolan RJ. Dopamine, time, and impulsivity in humans. J Neurosci 2010; 30: 8888-8896.
108. Salamone JD, Correa M, Farrar A, Mingote SM. Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits. Psychopharmacology (Berl) 2007; 191: 461-482.
109. Volkow N, Li TK. The neuroscience of addiction. Nat Neurosci 2005; 8: 1429-1430.
110. Volkow ND, Fowler JS, Wang GJ. The addicted human brain: insights from imaging studies. J Clin Invest 2003; 111: 1444-1451.
111. Volkow ND, Wang GJ, Fowler JS etal. Association of methylphenidate-induced craving with changes in right striato-orbitofrontal metabolism in cocaine abusers: implications in addiction. Am J Psychiatry 1999; 156: 19-26.
112. Wang GJ, Volkow ND, Fowler JS etal. Regional brain metabolic activation during craving elicited by recall of previous drug experiences. Life Sci 1999; 64: 775-784.
113. Grant S, London ED, Newlin DB etal. Activation of memory circuits during cue-elicited cocaine craving. Proc Natl Acad Sci U S A 1996; 93: 12040-12045.
114. Volkow ND, Wang GJ, Ma Y etal. Activation of orbital and medial prefrontal cortex by methylphenidate in cocaine-addicted subjects but not in controls: relevance to addiction. J Neurosci 2005; 25: 3932-3939.
115. Rolls ET, McCabe C. Enhanced affective brain representations of chocolate in cravers vs. non-cravers. Eur J Neurosci 2007; 26: 1067-1076.
116. Grabenhorst F, Rolls ET, Bilderbeck A. How cognition modulates affective responses to taste and flavor: top-down influences on the orbitofrontal and pregenual cingulate cortices. Cereb Cortex 2008; 18: 1549-1559.
117. Wang GJ, Volkow ND, Telang F etal. Exposure to appetitive food stimuli markedly activates the human brain. Neuroimage 2004; 21: 1790-1797.
118. Cox SM, Andrade A, Johnsrude IS. Learning to like: a role for human orbitofrontal cortex in conditioned reward. J Neurosci 2005; 25: 2733-2740.
119. Gallagher M, McMahan RW, Schoenbaum G. Orbitofrontal cortex and representation of incentive value in associative learning. J Neurosci 1999; 19: 6610-6614.
120. Weingarten HP. Conditioned cues elicit feeding in sated rats: a role for learning in meal initiation. Science 1983; 220: 431-433.
121. Ogden J, Wardle J. Cognitive restraint and sensitivity to cues for hunger and satiety. Physiol Behav 1990; 47: 477-481.
122. Machado CJ, Bachevalier J. The effects of selective amygdala, orbital frontal cortex or hippocampal formation lesions on reward assessment in nonhuman primates. Eur J Neurosci 2007; 25: 2885-2904.
123. Maayan L, Hoogendoorn C, Sweat V, Convit A. Disinhibited eating in obese adolescents is associated with orbitofrontal volume reductions and executive dysfunction. Obesity (Silver Spring) 2011; 19: 1382-1387.
124. Riggs NR, Huh J, Chou CP, Spruijt-Metz D, Pentz MA. Executive function and latent classes of childhood obesity risk. J Behav Med 2012; in press.
125. Riggs NR, Spruijt-Metz D, Chou CP, Pentz MA. Relationships between executive cognitive function and lifetime substance use and obesity-related behaviors in fourth grade youth. Child Neuropsychol 2012; 18: 1-11.
126. Walther K, Birdsill AC, Glisky EL, Ryan L. Structural brain differences and cognitive functioning related to body mass index in older females. Hum Brain Mapp 2010; 31: 1052-1064.
127. Gazdzinski S, Kornak J, Weiner MW, Meyerhoff DJ. Body mass index and magnetic resonance markers of brain integrity in adults. Ann Neurol 2008; 63: 652-657.
128. Pannacciulli N, Del Parigi A, Chen K, Le DS, Reiman EM, Tataranni PA. Brain abnormalities in human obesity: a voxel-based morphometric study. Neuroimage 2006; 31: 1419-1425.
129. Haltia LT, Viljanen A, Parkkola R etal. Brain white matter expansion in human obesity and the recovering effect of dieting. J Clin Endocrinol Metab 2007; 92: 3278-3284.
130. DelParigi A, Chen K, Salbe AD etal. Successful dieters have increased neural activity in cortical areas involved in the control of behavior. Int J Obes (Lond) 2007; 31: 440-448.
131. Bonson KR, Grant SJ, Contoreggi CS etal. Neural systems and cue-induced cocaine craving. Neuropsychopharmacology 2002; 26: 376-386.
132. Pelchat ML, Johnson A, Chan R, Valdez J, Ragland JD. Images of desire: food-craving activation during fMRI. Neuroimage 2004; 23: 1486-1493.
133. Wang Z, Faith M, Patterson F etal. Neural substrates of abstinence-induced cigarette cravings in chronic smokers. J Neurosci 2007; 27: 14035-14040.
134. Naqvi NH, Rudrauf D, Damasio H, Bechara A. Damage to the insula disrupts addiction to cigarette smoking. Science 2007; 315: 531-534.
135. Naqvi NH, Bechara A. The hidden island of addiction: the insula. Trends Neurosci 2009; 32: 56-67.
136. Clark L, Bechara A, Damasio H, Aitken MR, Sahakian BJ, Robbins TW. Differential effects of insular and ventromedial prefrontal cortex lesions on risky decision-making. Brain 2008; 131: 1311-1322.
137. Janes AC, Pizzagalli DA, Richardt S etal. Brain reactivity to smoking cues prior to smoking cessation predicts ability to maintain tobacco abstinence. Biol Psychiatry 2010; 67: 722-729.
138. Rolls ET. Functions of the orbitofrontal and pregenual cingulate cortex in taste, olfaction, appetite and emotion. Acta Physiol Hung 2008; 95: 131-164.
139. Craig AD. Interoception: the sense of the physiological condition of the body. Curr Opin Neurobiol 2003; 13: 500-505.
140. Wang GJ, Tomasi D, Backus W etal. Gastric distention activates satiety circuitry in the human brain. Neuroimage 2008; 39: 1824-1831.
141. Tomasi D, Wang GJ, Wang R etal. Association of body mass and brain activation during gastric distention: implications for obesity. Plos ONE 2009; 4: e6847.
142. Hajnal A, Norgren R. Taste pathways that mediate accumbens dopamine release by sapid sucrose. Physiol Behav 2005; 84: 363-369.
143. DelParigi A, Chen K, Salbe AD, Reiman EM, Tataranni PA. Sensory experience of food and obesity: a positron emission tomography study of the brain regions affected by tasting a liquid meal after a prolonged fast. Neuroimage 2005; 24: 436-443.
144. Frank GK, Oberndorfer TA, Simmons AN etal. Sucrose activates human taste pathways differently from artificial sweetener. Neuroimage 2008; 39: 1559-1569.
145. Wagner A, Aizenstein H, Mazurkewicz L etal. Altered insula response to taste stimuli in individuals recovered from restricting-type anorexia nervosa. Neuropsychopharmacology 2008; 33: 513-523.
146. Nummenmaa L, Hirvonen J, Hannukainen JC etal. Dorsal striatum and its limbic connectivity mediate abnormal anticipatory reward processing in obesity. Plos ONE 2012; 7: e31089.
147. Schultz W, Dayan P, Montague PR. A neural substrate of prediction and reward. Science 1997; 275: 1593-1599.
148. Matsumoto M, Hikosaka O. Lateral habenula as a source of negative reward signals in dopamine neurons. Nature 2007; 447: 1111-1115.
149. Christoph GR, Leonzio RJ, Wilcox KS. Stimulation of the lateral habenula inhibits dopamine-containing neurons in the substantia nigra and ventral tegmental area of the rat. J Neurosci 1986; 6: 613-619.
150. Lisoprawski A, Herve D, Blanc G, Glowinski J, Tassin JP. Selective activation of the mesocortico-frontal dopaminergic neurons induced by lesion of the habenula in the rat. Brain Res 1980; 183: 229-234.
151. Nishikawa T, Fage D, Scatton B. Evidence for, and nature of, the tonic inhibitory influence of habenulointerpeduncular pathways upon cerebral dopaminergic transmission in the rat. Brain Res 1986; 373: 324-336.
152. Kimura M, Satoh T, Matsumoto N. What does the habenula tell dopamine neurons? Nat Neurosci 2007; 10: 677-678.
153. Zhang F, Zhou W, Liu H etal. Increased c-Fos expression in the medial part of the lateral habenula during cue-evoked heroin-seeking in rats. Neurosci Lett 2005; 386: 133-137.
154. Brown RM, Short JL, Lawrence AJ. Identification of brain nuclei implicated in cocaine-primed reinstatement of conditioned place preference: a behaviour dissociable from sensitization. Plos ONE 2011; 5: e15889.
155. Fowler CD, Lu Q, Johnson PM, Marks MJ, Kenny PJ. Habenular alpha5 nicotinic receptor subunit signalling controls nicotine intake. Nature 2011; 471: 597-601.
156. Salas R, Sturm R, Boulter J, De Biasi M. Nicotinic receptors in the habenulo-interpeduncular system are necessary for nicotine withdrawal in mice. J Neurosci 2009; 29: 3014-3018.
157. Smith SL, Harrold JA, Williams G. Diet-induced obesity increases mu opioid receptor binding in specific regions of the rat brain. Brain Res 2002; 953: 215-222.
158. Jhou TC, Fields HL, Baxter MG, Saper CB, Holland PC. The rostromedial tegmental nucleus (RMTg), a GABAergic afferent to midbrain dopamine neurons, encodes aversive stimuli and inhibits motor responses. Neuron 2009; 61: 786-800.
159. Koob GF, Le Moal M. Addiction and the brain antireward system. Annu Rev Psychol 2008; 59: 29-53.
160. Ziauddeen H, Farooqi IS, Fletcher PC. Obesity and the brain: how convincing is the addiction model? Nat Rev Neurosci 2012; 13: 279-286.
161. Malik S, McGlone F, Bedrossian D, Dagher A. Ghrelin modulates brain activity in areas that control appetitive behavior. Cell Metab 2008; 7: 400-409.
162. Albarran-Zeckler RG, Sun Y, Smith RG. Physiological roles revealed by ghrelin and ghrelin receptor deficient mice. Peptides 2011; 32: 2229-2235.
163. Leggio L, Addolorato G, Cippitelli A, Jerlhag E, Kampov-Polevoy AB, Swift RM. Role of feeding-related pathways in alcohol dependence: a focus on sweet preference, NPY, and ghrelin. Alcohol Clin Exp Res 2011; 35: 194-202.
164. Aston-Jones G, Smith RJ, Sartor GC etal. Lateral hypothalamic orexin/hypocretin neurons: a role in reward-seeking and addiction. Brain Res 2010; 1314: 74-90.
165. James MH, Charnley JL, Levi EM etal. Orexin-1 receptor signalling within the ventral tegmental area, but not the paraventricular thalamus, is critical to regulating cue-induced reinstatement of cocaine-seeking. Int J Neuropsychopharmacol 2011; 14: 684-690.
166. Harris GC, Wimmer M, Randall-Thompson JF, Aston-Jones G. Lateral hypothalamic orexin neurons are critically involved in learning to associate an environment with morphine reward. Behav Brain Res 2007; 183: 43-51.
167. Cui H, Mason BL, Lee C, Nishi A, Elmquist JK, Lutter M. Melanocortin 4 receptor signaling in dopamine 1 receptor neurons is required for procedural memory learning. Physiol Behav 2012; 106: 201-210.
168. Proudnikov D, Hamon S, Ott J, Kreek MJ. Association of polymorphisms in the melanocortin receptor type 2 (MC2R, ACTH receptor) gene with heroin addiction. Neurosci Lett 2008; 435: 234-239.
169. Sajdyk TJ, Shekhar A, Gehlert DR. Interactions between NPY and CRF in the amygdala to regulate emotionality. Neuropeptides 2004; 38: 225-234.
170. Wu G, Feder A, Wegener G etal. Central functions of neuropeptide Y in mood and anxiety disorders. Expert Opin Ther Targets 2011; 15: 1317-1331.
171. Gilpin NW, Roberto M. Neuropeptide modulation of central amygdala neuroplasticity is a key mediator of alcohol dependence. Neurosci Biobehav Rev 2012; 36: 873-888.
172. Baicy K, London ED, Monterosso J etal. Leptin replacement alters brain response to food cues in genetically leptin-deficient adults. Proc Natl Acad Sci U S A 2007; 104: 18276-18279.
173. Farooqi IS, Bullmore E, Keogh J, Gillard J, O'Rahilly S, Fletcher PC. Leptin regulates striatal regions and human eating behavior. Science 2007; 317: 1355.
174. Scott MM, Lachey JL, Sternson SM etal. Leptin targets in the mouse brain. J Comp Neurol 2009; 514: 518-532.
175. Pravdova E, Macho L, Fickova M. Alcohol intake modifies leptin, adiponectin and resistin serum levels and their mRNA expressions in adipose tissue of rats. Endocr Regul 2009; 43: 117-125.
176. Fulton S, Pissios P, Manchon RP etal. Leptin regulation of the mesoaccumbens dopamine pathway. Neuron 2006; 51: 811-822.
177. Carr KD. Chronic food restriction: enhancing effects on drug reward and striatal cell signaling. Physiol Behav 2007; 91: 459-472.
178. Costello DA, Claret M, Al-Qassab H etal. Brain deletion of insulin receptor substrate 2 disrupts hippocampal synaptic plasticity and metaplasticity. Plos ONE 2012; 7: e31124.
179. Ernst A, Ma D, Garcia-Perez I etal. Molecular validation of the acute phencyclidine rat model for schizophrenia: identification of translational changes in energy metabolism and neurotransmission. J Proteome Res 2012; 11: 3704-3714.
180. Dube PE, Brubaker PL. Nutrient, neural and endocrine control of glucagon-like peptide secretion. Horm Metab Res 2004; 36: 755-760.
181. Dickson SL, Shirazi RH, Hansson C, Bergquist F, Nissbrandt H, Skibicka KP. The glucagon-like peptide 1 (GLP-1) analogue, Exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptors. J Neurosci 2012; 32: 4812-4820.
182. Erreger K, Davis AR, Poe AM, Greig NH, Stanwood GD, Galli A. Exendin-4 decreases amphetamine-induced locomotor activity. Physiol Behav 2012; 106: 574-578.
183. Hebb AL, Poulin JF, Roach SP, Zacharko RM, Drolet G. Cholecystokinin and endogenous opioid peptides: interactive influence on pain, cognition, and emotion. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29: 1225-1238.
184. Beinfeld MC. What we know and what we need to know about the role of endogenous CCK in psychostimulant sensitization. Life Sci 2003; 73: 643-654.
185. Vaccarino FJ. Nucleus accumbens dopamine-CCK interactions in psychostimulant reward and related behaviors. Neurosci Biobehav Rev 1994; 18: 207-214.
186. Crawley JN. Cholecystokinin potentiates dopamine-mediated behaviors in the nucleus accumbens, a site of CCK-DA co-existence. Psychopharmacol Bull 1985; 21: 523-527.
187. Marco A, Schroeder M, Weller A. Feeding and reward: ontogenetic changes in an animal model of obesity. Neuropharmacology 2012; 62: 2447-2454.
188. Batterham RL, Ffytche DH, Rosenthal JM etal. PYY modulation of cortical and hypothalamic brain areas predicts feeding behaviour in humans. Nature 2007; 450: 106-109.
189. Xu SL, Li J, Zhang JJ, Yu LC. Antinociceptive effects of galanin in the nucleus accumbens of rats. Neurosci Lett 2012; 520: 43-46.
190. Jin WY, Liu Z, Liu D, Yu LC. Antinociceptive effects of galanin in the central nucleus of amygdala of rats, an involvement of opioid receptors. Brain Res 2010; 1320: 16-21.
191. Ogren SO, Razani H, Elvander-Tottie E, Kehr J. The neuropeptide galanin as an in vivo modulator of brain 5-HT1A receptors: possible relevance for affective disorders. Physiol Behav 2007; 92: 172-179.
192. Morganstern I, Barson JR, Leibowitz SF. Regulation of drug and palatable food overconsumption by similar peptide systems. Curr Drug Abuse Rev 2011; 4: 163-173.
193. Barson JR, Morganstern I, Leibowitz SF. Galanin and consummatory behavior: special relationship with dietary fat, alcohol and circulating lipids. EXS 2011; 102: 87-111.
194. Fekete C, Lechan RM. Neuroendocrine implications for the association between cocaine- and amphetamine regulated transcript (CART) and hypophysiotropic thyrotropin-releasing hormone (TRH). Peptides 2006; 27: 2012-2018.
195. Millan EZ, Furlong TM, McNally GP. Accumbens shell-hypothalamus interactions mediate extinction of alcohol seeking. J Neurosci 2010; 30: 4626-4635.
196. Upadhya MA, Nakhate KT, Kokare DM, Singh U, Singru PS, Subhedar NK. CART peptide in the nucleus accumbens shell acts downstream to dopamine and mediates the reward and reinforcement actions of morphine. Neuropharmacology 2012; 62: 1823-1833.
197. Zambello E, Jimenez-Vasquez PA, El Khoury A, Mathe AA, Caberlotto L. Acute stress differentially affects corticotropin-releasing hormone mRNA expression in the central amygdala of the 'depressed' flinders sensitive line and the control flinders resistant line rats. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32: 651-661.
198. Caberlotto L, Rimondini R, Hansson A, Eriksson S, Heilig M. Corticotropin-releasing hormone (CRH) mRNA expression in rat central amygdala in cannabinoid tolerance and withdrawal: evidence for an allostatic shift? Neuropsychopharmacology 2004; 29: 15-22.
199. Cippitelli A, Damadzic R, Singley E etal. Pharmacological blockade of corticotropin-releasing hormone receptor 1 (CRH1R) reduces voluntary consumption of high alcohol concentrations in non-dependent Wistar rats. Pharmacol Biochem Behav 2012; 100: 522-529.
200. Le Strat Y, Dubertret C. [The role of genetic factors on the link between stress and alcohol use: the example of CRH-R1]. Presse Med 2012; 41: 32-36.
201. Inoue H, Yamasue H, Tochigi M etal. Association between the oxytocin receptor gene and amygdalar volume in healthy adults. Biol Psychiatry 2010; 68: 1066-1072.
202. Subiah CO, Mabandla MV, Phulukdaree A, Chuturgoon AA, Daniels WM. The effects of vasopressin and oxytocin on methamphetamine-induced place preference behaviour in rats. Metab Brain Dis 2012; 27: 341-350.
203. Blum K, Braverman ER, Wood RC etal. Increased prevalence of the Taq I A1 allele of the dopamine receptor gene (DRD2) in obesity with comorbid substance use disorder: a preliminary report. Pharmacogenetics 1996; 6: 297-305.
204. Skibicka KP, Shirazi RH, Hansson C, Dickson SL. Ghrelin interacts with neuropeptide Y Y1 and opioid receptors to increase food reward. Endocrinology 2012; 153: 1194-1205.
205. Olszewski PK, Alsio J, Schioth HB, Levine AS. Opioids as facilitators of feeding: can any food be rewarding? Physiol Behav 2011; 104: 105-110.
206. Davis CA, Levitan RD, Reid C etal. Dopamine for 'wanting' and opioids for 'liking': a comparison of obese adults with and without binge eating. Obesity (Silver Spring) 2009; 17: 1220-1225.
207. Katona I, Freund TF. Multiple functions of endocannabinoid signaling in the brain. Annu Rev Neurosci 2012; 35: 529-558.
208. Bermudez-Silva FJ, Cardinal P, Cota D. The role of the endocannabinoid system in the neuroendocrine regulation of energy balance. J Psychopharmacol 2011; 26: 114-124.
209. Leibowitz SF, Alexander JT. Hypothalamic serotonin in control of eating behavior, meal size, and body weight. Biol Psychiatry 1998; 44: 851-864.
210. Halford JC, Harrold JA. 5-HT(2C) receptor agonists and the control of appetite. Handb Exp Pharmacol 2012; 209: 349-356.
211. Blandina P, Munari L, Provensi G, Passani MB. Histamine neurons in the tuberomamillary nucleus: a whole center or distinct subpopulations? Front Syst Neurosci 2012; 6: 33.
212. Nuutinen S, Lintunen M, Vanhanen J, Ojala T, Rozov S, Panula P. Evidence for the role of histamine H3 receptor in alcohol consumption and alcohol reward in mice. Neuropsychopharmacology 2011; 36: 2030-2040.
213. Galici R, Rezvani AH, Aluisio L etal. JNJ-39220675, a novel selective histamine H3 receptor antagonist, reduces the abuse-related effects of alcohol in rats. Psychopharmacology (Berl) 2011; 214: 829-841.
214. Miszkiel J, Kruk M, McCreary AC, Przegalinski E, Biala G, Filip M. Effects of the histamine (H)3 receptor antagonist ABT-239 on acute and repeated nicotine locomotor responses in rats. Pharmacol Rep 2011; 63: 1553-1559.
215. Malmlof K, Zaragoza F, Golozoubova V etal. Influence of a selective histamine H3 receptor antagonist on hypothalamic neural activity, food intake and body weight. Int J Obes (Lond) 2005; 29: 1402-1412.
216. Jo Y, Talmage D, Role L. Nicotinic receptor-mediated effects on appetite and food intake. J Neurobiol 2002; 53: 618-632.
217. Miyata G, Meguid MM, Fetissov SO, Torelli GF, Kim HJ. Nicotine's effect on hypothalamic neurotransmitters and appetite regulation. Surgery 1999; 126: 255-263.
218. White MA, Masheb RM, Grilo CM. Self-reported weight gain following smoking cessation: a function of binge eating behavior. Int J Eat Disord 2009; 43: 572-575.
219. Stanley BG, Willett VL 3rd, Donias HW, Ha LH, Spears LC. The lateral hypothalamus: a primary site mediating excitatory amino acid-elicited eating. Brain Res 1993; 630: 41-49.
220. Hettes SR, Gonzaga WJ, Heyming TW, Nguyen JK, Perez S, Stanley BG. Stimulation of lateral hypothalamic AMPA receptors may induce feeding in rats. Brain Res 2010; 1346: 112-120.
221. Xu Y, O'Brien WG 3rd, Lee CC, Myers MG Jr, Tong Q. Role of GABA release from leptin receptor-expressing neurons in body weight regulation. Endocrinology 2012; 153: 2223-2233.
222. Taylor K, Lester E, Hudson B, Ritter S. Hypothalamic and hindbrain NPY, AGRP and NE increase consummatory feeding responses. Physiol Behav 2007; 90: 744-750.
223. Otis JM, Mueller D. Inhibition of beta-adrenergic receptors induces a persistent deficit in retrieval of a cocaine-associated memory providing protection against reinstatement. Neuropsychopharmacology 2011; 9: 1912-1920.
224. Miranda MI, LaLumiere RT, Buen TV, Bermudez-Rattoni F, McGaugh JL. Blockade of noradrenergic receptors in the basolateral amygdala impairs taste memory. Eur J Neurosci 2003; 18: 2605-2610.
225. Gutierrez R, Lobo MK, Zhang F, de Lecea L. Neural integration of reward, arousal, and feeding: recruitment of VTA, lateral hypothalamus, and ventral striatal neurons. IUBMB Life. 2011; 63: 824-830.
226. Carnell S, Gibson C, Benson L, Ochner CN, Geliebter A. Neuroimaging and obesity: current knowledge and future directions. Obes Rev 2011; 13: 43-56.